Adagio Medical Holdings, Inc. (ADGM) Research

Adagio Medical Holdings, Inc. is an emerging medical device firm focused on pioneering and commercializing innovative ablation technologies. Its core mission is to provide therapeutic solutions for various cardiac rhythm disorders, including but not limited to atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's current product portfolio showcases advanced offerings such as the iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and its complementary accessories, the vCLAS ventricular ULTC catheter, and the Cryopulse atrial pulsed-field cryoablation catheter, also available with associated accessories. This entity, which commenced operations in 2011, has its principal office situated in Laguna Hills, California.

Market snapshot

Symbol
ADGM
Price
$0.68
Day change
-2.86%
Market cap
$10.4M
P/E ratio
-0.62x
52-week range
0.68-2.582
Sector
Healthcare
Industry
Medical - Devices
Next earnings
in 2 months
Analyst price target
$3.00

Peer companies

  • Allurion Technologies Inc. (ALUR)
  • Athira Pharma, Inc. (ATHA)
  • Envoy Medical, Inc. (COCH)
  • Co-Diagnostics, Inc. (CODX)
  • Citius Pharmaceuticals, Inc. (CTXR)
  • IRIDEX Corporation (IRIX)
  • Leap Therapeutics, Inc. (LPTX)
  • enVVeno Medical Corporation (NVNO)

Recent insider activity

  • Kaster Deborah — A-Award (490500 shares) on 2026-03-06
  • Usen Todd — A-Award (800000 shares) on 2026-03-06
  • Kaster Deborah — P-Purchase (15000 shares) on 2025-12-16
  • Usen Todd — P-Purchase (207315 shares) on 2025-12-12
  • Salmon Sean — A-Award (90000 shares) on 2025-12-11

Open Adagio Medical Holdings, Inc. (ADGM) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.